共 50 条
- [31] Class III β-tubulin is a marker of paclitaxel resistance in carcinomas of unknown primary site Cancer Chemotherapy and Pharmacology, 2007, 60
- [34] METASTATIC ADENOCARCINOMAS OF UNKNOWN PRIMARY SITE - PROGNOSTIC VARIABLES AND TREATMENT RESULTS AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (01): : 55 - 60